동물용 현장 진단 진단 시장 예측(-2034년) : 제품 유형, 진단 기술, 동물종, 적응증, 검체 유형별, 최종사용자, 용도, 유통 채널 및 지역별 분석

According to Stratistics MRC, the Global Veterinary Point-of-Care Diagnostics Market is accounted for $2.9 billion in 2026 and is expected to reach $6.7 billion by 2034 growing at a CAGR of 10.9% during the forecast period. Veterinary point-of-care diagnostics refer to diagnostic tests and systems performed at or near the site of patient care, enabling rapid, real-time clinical decision-making for animal health. The market encompasses instruments and analyzers including benchtop and portable/handheld analyzers, test kits and consumables such as reagent kits, test strips, cartridges and cassettes, and controls and calibrators, along with software and data management solutions. Diagnostic technologies include immunodiagnostics, molecular diagnostics, clinical biochemistry, hematology, blood gas and electrolyte analysis, urinalysis, coagulation testing, microbiology testing, and other diagnostic technologies. Growing pet ownership, increasing demand for rapid diagnostic results, rising prevalence of chronic and infectious diseases in animals, and technological advancements in diagnostic platforms are key drivers of market expansion across all regions.

Market Dynamics:

Driver:

Growing demand for rapid and accurate diagnostic results

The increasing need for timely and accurate diagnostic information to enable prompt clinical decision-making is a primary driver for the veterinary point-of-care diagnostics market. Veterinarians require rapid test results to initiate appropriate treatment, particularly in emergency and critical care situations where time is critical. Point-of-care diagnostics eliminate the delays associated with sending samples to reference laboratories, enabling immediate clinical action. The growing complexity of veterinary cases and increasing owner expectations for rapid answers drive demand for in-clinic testing. As veterinary medicine advances and treatment options expand, the need for rapid diagnostic support continues growing, sustaining strong market expansion.

Restraint:

High equipment costs and limited practice budgets

The significant capital investment required for point-of-care diagnostic equipment and ongoing consumable costs represent a major restraint for the market. Advanced analyzers and diagnostic platforms require substantial upfront investment that may be challenging for smaller practices. Ongoing consumable costs including reagents, test kits, and calibrators add to operational expenses. Reimbursement limitations for veterinary diagnostics affect practice economics. Limited budgets, particularly in small and rural practices, may restrict equipment acquisition. These cost barriers may limit adoption and market growth, especially in developing regions and among smaller veterinary practices.

Opportunity:

Technological advancements in miniaturization and connectivity

Continuous innovation in diagnostic technologies including miniaturization, connectivity, and user-friendly platforms presents significant opportunities for market expansion. Portable and handheld analyzers enable testing in diverse settings including field practice, large animal medicine, and mobile clinics. Wireless connectivity and cloud-based data management enable seamless integration with practice management software and telemedicine platforms. AI-powered interpretation and decision support tools are enhancing diagnostic accuracy. User-friendly interfaces reduce training requirements. As technology becomes more accessible and affordable, new applications and expanded access capture growing market share, expanding the addressable market.

Threat:

Competition from reference laboratories and centralized testing

Competition from established reference laboratories and centralized testing services poses significant threats to the veterinary point-of-care diagnostics market. Reference laboratories offer comprehensive test menus, specialized expertise, and economies of scale. Some veterinarians may prefer referral laboratory testing for complex cases or when point-of-care capabilities are limited. The convenience of sample pickup and comprehensive reporting may favor centralized testing. Cost considerations may make reference laboratory testing more economical for certain tests. This competition may limit point-of-care adoption for certain test categories and practices.

Covid-19 Impact:

The COVID-19 pandemic had a significant impact on the veterinary point-of-care diagnostics market. Initial disruptions included reduced veterinary visits during lockdowns and supply chain interruptions. However, pet adoption surged during the pandemic, expanding the patient population. The pandemic accelerated demand for rapid diagnostics and in-clinic testing capabilities. Increased focus on infection control and biosecurity drove interest in point-of-care solutions. Telemedicine expansion increased demand for diagnostic data connectivity. Post-pandemic, elevated pet ownership and continued focus on rapid diagnostics have sustained market growth, with practices maintaining investment in point-of-care capabilities.

The Instruments and Analyzers segment is expected to be the largest during the forecast period

The Instruments and Analyzers segment is expected to account for the largest market share during the forecast period, driven by the essential role of diagnostic platforms in enabling comprehensive point-of-care testing across multiple test categories. Instruments and analyzers including benchtop and portable/handheld systems are the foundation of veterinary point-of-care diagnostics, providing the hardware necessary for conducting tests and generating results. The segment benefits from continuous innovation including miniaturization and connectivity advancements. Ongoing replacement and upgrade cycles sustain demand. As practices invest in diagnostic capabilities, instruments and analyzers remain the largest product segment, securing the largest market share throughout the forecast period.

The Molecular Diagnostics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Molecular Diagnostics segment is predicted to witness the highest growth rate, fueled by increasing demand for rapid, accurate infectious disease detection, growing availability of point-of-care molecular platforms, and technological advancements enabling simpler, faster testing. Molecular diagnostics including PCR-based tests and isothermal amplification tests offer high sensitivity and specificity for detecting pathogens at the genetic level. The segment benefits from expanding applications in infectious disease testing, genetic testing, and antimicrobial resistance detection. Growing availability of user-friendly, rapid molecular platforms suitable for point-of-care use is driving adoption. As molecular testing becomes more accessible and affordable, this segment delivers the fastest market growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high pet ownership rates, strong veterinary spending, and established point-of-care diagnostics adoption. The United States leads regional market growth with extensive veterinary practice infrastructure and high diagnostic testing utilization. High awareness of advanced diagnostic options among pet owners supports demand. Strong presence of diagnostic equipment manufacturers drives innovation. Established veterinary reference networks and specialty practices create consistent demand. With high pet healthcare spending and advanced veterinary infrastructure, North America maintains its dominant market position.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by rising pet ownership, increasing disposable incomes, and growing awareness of advanced veterinary diagnostics across countries including China, India, Australia, and Southeast Asia. The region's rapidly growing pet population and expanding middle class create substantial demand for veterinary services. Veterinary practice modernization and technology adoption are accelerating. Increasing investment in veterinary education and diagnostic infrastructure supports market expansion. Growing awareness of point-of-care diagnostics benefits and expanding pet insurance coverage further accelerate adoption. As veterinary healthcare develops and pet spending increases, Asia Pacific delivers the fastest veterinary point-of-care diagnostics market growth globally.

Key players in the market

Some of the key players in Veterinary Point-of-Care Diagnostics Market include IDEXX Laboratories, Inc., Zoetis Inc., Heska Corporation, Virbac S.A., Thermo Fisher Scientific Inc., FUJIFILM Corporation, Randox Laboratories Ltd., bioMerieux SA, QIAGEN N.V., BioNote, Inc., SEKISUI Diagnostics, LLC, Woodley Equipment Company Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., INDICAL BIOSCIENCE GmbH, Bionote USA Inc., and Neogen Corporation.

Key Developments:

In May 2026, IDEXX Laboratories expanded its Fecal Dx antigen testing platform by adding Taeniid tapeworm detection capabilities to improve point-of-care parasitic screening for companion animals.

In March 2026, Zoetis entered into a definitive agreement to acquire the global animal genomics business from Neogen Corporation, expanding its precision animal health and predictive diagnostic insights portfolio across livestock and companion animals.

In March 2026, Neogen Corporation announced the divestiture of its global animal genomics business unit to Zoetis, realigning its resources to focus on core food safety, indicator media, and specialized point-of-care sanitation platforms.

In September 2025, FUJIFILM Healthcare Europe launched the FUJI DRI-CHEM AU20V in-house diagnostics measurement device, featuring automated dilution and Surface Plasmon Fluorescence (SPF) technology to deliver point-of-care endocrine and hormone results in 10 minutes.

Products Covered:

• Instruments and Analyzers
• Test Kits and Consumables
• Software and Data Management Solutions

Diagnostic Technologies Covered:

• Immunodiagnostics
• Molecular Diagnostics
• Clinical Biochemistry
• Hematology
• Blood Gas and Electrolyte Analysis
• Urinalysis
• Coagulation Testing
• Microbiology Testing
• Other Diagnostic Technologies

Animal Types Covered:

• Companion Animals
• Livestock Animals

Indications Covered:

• Infectious Diseases
• Parasitic Diseases
• Endocrine Disorders
• Cardiac Disorders
• Renal Diseases
• Hepatic Diseases
• Gastrointestinal Disorders
• Respiratory Diseases
• Reproductive Health Disorders
• Metabolic Disorders
• Other Indications

Sample Types Covered:

• Blood
• Serum and Plasma
• Urine
• Fecal Samples
• Saliva
• Tissue Samples
• Milk
• Other Sample Types

End Users Covered:

• Veterinary Hospitals and Clinics
• Veterinary Diagnostic Laboratories
• Livestock Farms and Dairy Farms
• Research Institutes and Universities
• Animal Shelters and Rescue Centers
• Home Care Settings
• Other End Users

Applications Covered:

• Disease Diagnosis
• Wellness Screening
• Pregnancy Testing
• Pre-Surgical Testing
• Treatment Monitoring
• Herd Health Monitoring
• Emergency and Critical Care Diagnostics
• Other Applications

Distribution Channels Covered:

• Direct Sales
• Veterinary Distributors
• Retail Pharmacies
• E-Commerce Platforms
• Other Distribution Channels

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Veterinary Point-of-Care Diagnostics Market, By Product

• 5.1 Instruments and Analyzers
  • 5.1.1 Benchtop Analyzers
  • 5.1.2 Portable/Handheld Analyzers
• 5.2 Test Kits and Consumables
  • 5.2.1 Reagent Kits
  • 5.2.2 Test Strips
  • 5.2.3 Cartridges and Cassettes
  • 5.2.4 Controls and Calibrators
• 5.3 Software and Data Management Solutions

6 Global Veterinary Point-of-Care Diagnostics Market, By Diagnostic Technology

• 6.1 Immunodiagnostics
  • 6.1.1 Lateral Flow Assays
  • 6.1.2 ELISA-Based Rapid Tests
• 6.2 Molecular Diagnostics
  • 6.2.1 PCR-Based Tests
  • 6.2.2 Isothermal Amplification Tests
• 6.3 Clinical Biochemistry
• 6.4 Hematology
• 6.5 Blood Gas and Electrolyte Analysis
• 6.6 Urinalysis
• 6.7 Coagulation Testing
• 6.8 Microbiology Testing
• 6.9 Other Diagnostic Technologies

7 Global Veterinary Point-of-Care Diagnostics Market, By Animal Type

• 7.1 Companion Animals
  • 7.1.1 Dogs
  • 7.1.2 Cats
  • 7.1.3 Horses
  • 7.1.4 Other Companion Animals
• 7.2 Livestock Animals
  • 7.2.1 Cattle
  • 7.2.2 Swine
  • 7.2.3 Poultry
  • 7.2.4 Sheep and Goats
  • 7.2.5 Other Livestock Animals

8 Global Veterinary Point-of-Care Diagnostics Market, By Indication

• 8.1 Infectious Diseases
• 8.2 Parasitic Diseases
• 8.3 Endocrine Disorders
• 8.4 Cardiac Disorders
• 8.5 Renal Diseases
• 8.6 Hepatic Diseases
• 8.7 Gastrointestinal Disorders
• 8.8 Respiratory Diseases
• 8.9 Reproductive Health Disorders
• 8.10 Metabolic Disorders
• 8.11 Other Indications

9 Global Veterinary Point-of-Care Diagnostics Market, By Sample Type

• 9.1 Blood
• 9.2 Serum and Plasma
• 9.3 Urine
• 9.4 Fecal Samples
• 9.5 Saliva
• 9.6 Tissue Samples
• 9.7 Milk
• 9.8 Other Sample Types

10 Global Veterinary Point-of-Care Diagnostics Market, By End User

• 10.1 Veterinary Hospitals and Clinics
• 10.2 Veterinary Diagnostic Laboratories
• 10.3 Livestock Farms and Dairy Farms
• 10.4 Research Institutes and Universities
• 10.5 Animal Shelters and Rescue Centers
• 10.6 Home Care Settings
• 10.7 Other End Users

11 Global Veterinary Point-of-Care Diagnostics Market, By Application

• 11.1 Disease Diagnosis
• 11.2 Wellness Screening
• 11.3 Pregnancy Testing
• 11.4 Pre-Surgical Testing
• 11.5 Treatment Monitoring
• 11.6 Herd Health Monitoring
• 11.7 Emergency and Critical Care Diagnostics
• 11.8 Other Applications

12 Global Veterinary Point-of-Care Diagnostics Market, By Distribution Channel

• 12.1 Direct Sales
• 12.2 Veterinary Distributors
• 12.3 Retail Pharmacies
• 12.4 E-Commerce Platforms
• 12.5 Other Distribution Channels

13 Global Veterinary Point-of-Care Diagnostics Market, By Geography

• 13.1 North America
  • 13.1.1 United States
  • 13.1.2 Canada
  • 13.1.3 Mexico
• 13.2 Europe
  • 13.2.1 United Kingdom
  • 13.2.2 Germany
  • 13.2.3 France
  • 13.2.4 Italy
  • 13.2.5 Spain
  • 13.2.6 Netherlands
  • 13.2.7 Belgium
  • 13.2.8 Sweden
  • 13.2.9 Switzerland
  • 13.2.10 Poland
  • 13.2.11 Rest of Europe
• 13.3 Asia Pacific
  • 13.3.1 China
  • 13.3.2 Japan
  • 13.3.3 India
  • 13.3.4 South Korea
  • 13.3.5 Australia
  • 13.3.6 Indonesia
  • 13.3.7 Thailand
  • 13.3.8 Malaysia
  • 13.3.9 Singapore
  • 13.3.10 Vietnam
  • 13.3.11 Rest of Asia Pacific
• 13.4 South America
  • 13.4.1 Brazil
  • 13.4.2 Argentina
  • 13.4.3 Colombia
  • 13.4.4 Chile
  • 13.4.5 Peru
  • 13.4.6 Rest of South America
• 13.5 Rest of the World (RoW)
  • 13.5.1 Middle East
    • 13.5.1.1 Saudi Arabia
    • 13.5.1.2 United Arab Emirates
    • 13.5.1.3 Qatar
    • 13.5.1.4 Israel
    • 13.5.1.5 Rest of Middle East
  • 13.5.2 Africa
    • 13.5.2.1 South Africa
    • 13.5.2.2 Egypt
    • 13.5.2.3 Morocco
    • 13.5.2.4 Rest of Africa

14 Strategic Market Intelligence

• 14.1 Industry Value Network and Supply Chain Assessment
• 14.2 White-Space and Opportunity Mapping
• 14.3 Product Evolution and Market Life Cycle Analysis
• 14.4 Channel, Distributor, and Go-to-Market Assessment

15 Industry Developments and Strategic Initiatives

• 15.1 Mergers and Acquisitions
• 15.2 Partnerships, Alliances, and Joint Ventures
• 15.3 New Product Launches and Regulatory Approvals
• 15.4 Capacity Expansion and Investments
• 15.5 Other Strategic Initiatives

16 Company Profiles

• 16.1 IDEXX Laboratories, Inc.
• 16.2 Zoetis Inc.
• 16.3 Heska Corporation
• 16.4 Virbac S.A.
• 16.5 Thermo Fisher Scientific Inc.
• 16.6 FUJIFILM Corporation
• 16.7 Randox Laboratories Ltd.
• 16.8 bioMerieux SA
• 16.9 QIAGEN N.V.
• 16.10 BioNote, Inc.
• 16.11 SEKISUI Diagnostics, LLC
• 16.12 Woodley Equipment Company Ltd.
• 16.13 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 16.14 INDICAL BIOSCIENCE GmbH
• 16.15 Bionote USA Inc.
• 16.16 Neogen Corporation